Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes

Tarja Myntti1, Leena Rahkonen1, Irmeli Nupponen2

  • 1Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Disease Markers
|February 8, 2017
PubMed

Insights

Neutrophil-based biomarkers in amniotic fluid show high sensitivity for detecting intra-amniotic infection (IAI) and microbial invasion of the amniotic cavity (MIAC) in preterm pregnancies. These findings aid in diagnosing IAI and MIAC, improving neonatal outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Intra-amniotic infection (IAI) is a significant cause of preterm labor and poor neonatal outcomes.
  • Identifying IAI and microbial invasion of the amniotic cavity (MIAC) in preterm pregnancies is crucial for timely intervention.

Purpose of the Study:

  • To evaluate amniotic fluid (AF) proteolytic cascade biomarkers for their association with MIAC and IAI in preterm pregnancies with intact membranes.
  • To assess the diagnostic potential of specific AF biomarkers in relation to infection and microbial presence.

Main Methods:

  • Amniotic fluid samples were collected from 73 women with singleton pregnancies (27 suspected IAI, 46 controls).
  • Biomarkers from three proteolytic cascades (including MMP-8, MMP-9, MPO, HNE, elafin, TIMP-1, CRP) were measured using immunoassays and ELISA.
  • Microbiological methods were used to detect MIAC.

Main Results:

  • Elevated concentrations of MMP-8, MMP-9, MPO, elafin, and TIMP-1 were observed in IAI-suspected cases and in cases with MIAC.
  • Most biomarkers demonstrated 100% sensitivity for detecting IAI/MIAC based on ROC curve analysis.
  • Biomarkers showed significant odd ratios for MIAC, indicating their predictive value.

Conclusions:

  • Neutrophil-derived amniotic fluid biomarkers are strongly associated with IAI and MIAC in preterm pregnancies.
  • These biomarkers hold promise for the early diagnosis and management of intra-amniotic infections.
  • Further research can refine the use of these biomarkers for improved neonatal care.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.4K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.2K